Financing

Celon Pharma SA

06/05/2026 06:28

May 6 (Reuters) - Celon Pharma SA CLNP.WA:

SAID ON TUESDAY FOUR OF ITS PROJECTS WERE RECOMMENDED FOR CO-FINANCING BY POLAND'S MEDICAL RESEARCH AGENCY

TOTAL AMOUNT OF CO-FINANCING FOR THE PROJECTS IS 39.3 MILLION ZLOTYS

PROJECTS INCLUDE DEVELOPING A THERAPY FOR SOLID TUMORS, AN MRNA DELIVERY PLATFORM, AND TWO PAIN TREATMENTS

PROJECTS ARE TO BE CARRIED OUT FROM JAN. 1, 2026, TO DEC. 31, 2028

 Source text for Workspace: nEM416VJxa
 Further company coverage: CLNP.WA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))